SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

CLV Clover Corporation Limited

Consumer Defensive · Packaged Foods · website · 81 employees
$1.03
52wk 0.61 – 1.17
Overall
78.5
Value
66.7
Growth
70.6
Health
100.0
Quality
78.3
Momentum
76.2
Dividend
78.5
Price
About Clover Corporation Limited

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

Price analytics

Returns

1 day -1.4%
1 week -4.6%
1 month 16.4%
3 months 36.4%
6 months -1.4%
1 year 50.4%
3 years 8.4%

Risk

Volatility (1y ann.) 55.5%
Beta vs ASX 200 0.33
Sharpe (1y) 0.93
VaR 95% (1-day) -4.4%
Max drawdown (1y) -31.3%
Off 1-year high -5.1%

Technicals

RSI(14) 66
vs 50DMA 9.9%
vs 200DMA 18.0%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 66.7
Trailing P/E
71
Forward P/E
90
PEG ratio
6
EV / EBITDA
65
Price / Book
81
Price / Sales
90
Growth 70.6
Revenue growth (1y)
100
Revenue CAGR (3y)
47
EPS growth (1y)
100
EPS CAGR (3y)
27
Financial Health 100.0
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 78.3
Return on equity
70
Return on assets
100
Operating margin
77
Net margin
72
Cash conversion (OCF / net income)
—
Dividend / Income 78.5
Dividend yield (%)
40
Payout ratio
100
FCF dividend cover
100
Momentum 76.2
6-month return vs ASX 200
41
Price vs 200-day average
100
Price vs 50-day average
100
Position in 52-week range
76

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$172.01M
P/E (trailing)
17.17
P/E (forward)
10.62
EPS (trailing)
0.06
Dividend yield
2.4%
Payout ratio
31.9%
Beta
-0.28
EV / EBITDA
9.42
Price / Book
2.20
ROE
13.9%
Operating margin
19.2%
Net margin
10.7%
Total cash
$7.22M
Total debt
$1.07M
Current ratio
3.73
Debt / Equity
0.01
Free cash flow
$5.80M
Avg volume
116,919
Latest annual results (FY ending 31 Jul 2025)
  • Revenue$86.00M
  • Gross profit$26.17M
  • Operating income$8.33M
  • Net income$7.01M
  • Diluted EPS0.04
  • Free cash flow$6.95M
  • Net debt-$6.26M
Sector peers (Consumer Defensive)
TickerMkt cap P/EScore
WOW $46.85B 41.7 35.9
COL $30.95B 28.4 42.5
EDV $5.35B 99.3 24.2
A2M $4.86B 29.0 48.3
TWE $4.54B — 51.6
MTS $3.18B 11.6 48.9
BGA $1.92B 34.8 44.4
GNC $1.43B — 35.9